Physician profile
Yang Kim
NPI 1528055456
$996.53
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $67.47 · 2021: $123 · 2022: $193 · 2023: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $415.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $236.75 | 2023 | Dupixent |
| Sanofi Pasteur INC. | $231.57 | 2019-2023 | |
| Abbvie INC. | $138.23 | 2019-2021 | |
| Cranial Technologies, INC | $79.30 | 2019-2023 | Doc Band |
| Merck Sharp & Dohme LLC | $73.35 | 2019-2021 | |
| Glaxosmithkline, LLC. | $61.60 | 2020-2023 | Pediarix, Rotarix, Bexsero |
| Pfizer INC. | $30.94 | 2021 | |
| Janssen Biotech, INC. | $25.55 | 2022 | |
| Alexion Pharmaceuticals, INC. | $23.00 | 2019 | |
| Hologic Sales and Service, LLC | $22.38 | 2021 | |
| Roche Diagnostics Corporation | $22.17 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.56 | 2023 | |
| Alk-Abello, INC | $18.13 | 2023 | Grastek, Odactra, Ragwitek |
| Boston Scientific Corporation | $15.00 | 2023 | Lux-Dx Insertable Cardiac Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yang Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.